№ lp_2_1_16804
File format: docx
Character count: 2406
File size: 454 KB
This form is used for referring patients to the emergency eye clinic, providing detailed patient and medical history information for optometrists or GPs to complete when referring cases.
Note:
Year
Theme:
Ophthalmology
Document Type:
Referral Form
Organization / Institution:
Royal Cornwall Hospital Trust
Target Audience:
Community Optometrists, GPs
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Date:
October 28, 2023
Organization:
Alcoholics Anonymous
Group:
Eye Opener Group
District:
District 5
Area:
Area 15
Document type:
Group Service Representative report
Author:
John S.
Role:
Group Service Representative
Reporting period:
September–October 2023
Meetings referenced:
District 5 Business Meeting; Area 15 Quarterly Assembly
Financial period reported:
September 2023
Committees mentioned:
Accessibilities Committee; Area 15 Outreach Committee; Area 15 Finance Committee
Locations mentioned:
Charlotte Behavioral Center; Port Charlotte, Florida; Zoom
Source type:
Internal service report
Year:
2018
Region / city:
Philadelphia, PA
Theme:
Ophthalmology, Data Management
Document Type:
Solicitation Notice
Organization / institution:
Department of Veterans Affairs
Author:
Thomas A. Cossentino
Target Audience:
Service-Disabled Veteran-Owned Small Businesses
Period of Action:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Context:
Combined synopsis/solicitation notice for the procurement of a Zeiss Integrated Ophthalmic Data Management System to be used at the Corporal Michael J. Crescenz VA Medical Center and its satellite eye clinics.
Year:
2025
Region / City:
[insert local health board name]
Subject:
Healthcare, Pharmacy Services
Document Type:
Patient Group Direction (PGD)
Organization / Institution:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett
Target Audience:
Pharmacists
Validity Period:
From 01 April 2025 to 31 March 2028
Approval Date:
11 February 2025
Amendment Date:
28 January 2025
Year:
2025
Region / city:
[insert local health board name]
Subject:
Pharmaceutical Service, Public Health
Document type:
Patient Group Direction (PGD)
Organ / institution:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, National Lead Pharmacist, Medicines Advice
Target audience:
Pharmacists, Healthcare professionals
Validity period:
01 April 2025 – 31 March 2028
Approval date:
11 February 2025
Amendment date:
06 January 2025
Year:
2024-2025
Region / City:
Washington State
Topic:
Medical authorization form
Document Type:
Medical Authorization
Organization:
Washington State School for the Blind
Author:
Licensed Health Professional
Target Audience:
Parents/Guardians, School Staff
Effective Period:
07/01/2024 - 08/31/2025
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
Cambridgeshire
Theme:
Environmental Regulation, Waste Management
Document Type:
Decision Record
Agency / Institution:
Environment Agency
Author:
Not specified
Target Audience:
Stakeholders in environmental and waste management sectors
Validity Period:
Indefinite
Approval Date:
2026-02-01
Amendment Date:
None
Year:
2019
Region / city:
Australia
Topic:
Medical device, eye care
Document type:
Public Summary Document
Organ / institution:
Therapeutic Goods Administration (TGA), Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Allergan Australia Pty Ltd
Target audience:
Healthcare professionals, medical practitioners
Period of validity:
Not specified
Approval date:
13 March 2019
Date of amendments:
Not specified
Year:
2007
Region / City:
Dublin
Topic:
Eye tests for VDU work, employee health benefits
Document type:
Application form
Organization / Institution:
City of Dublin ETB
Author:
Not specified
Target audience:
City of Dublin ETB staff
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Note:
Contextual description
Note:
Date
Follow the Six Rights of Medication Administration:
Right student, Right medication, Right dose, Right time, Right route and Right documentation. Know which eye is to be treated. Initials may be used to specify the eye that requires treatment, O.D. = right eye; O.S. = left eye; O.U. = both eyes.
Topic:
Medication administration
Document Type:
Training checklist
Organization:
School
Author:
Not specified
Target Audience:
Staff administering medication
Period of validity:
School year
Year:
Date of Birth:
Region / City:
Athlone
Subject:
Eye Test, VDU Equipment
Document Type:
Form
Organization / Institution:
TUS Athlone Campus
Author:
Unknown
Target Audience:
Applicants
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / City:
Dakota, Ramsey, Washington
Theme:
Environmental Remediation
Document Type:
Work Plan
Organization:
Minnesota Pollution Control Agency
Author:
Michael Varien, Paul Pestano
Target Audience:
Stakeholders in environmental remediation, public health, and local governance
Action Period:
August 2022 - June 2026
Approval Date:
August 16, 2022
Amendment Date:
N/A
Medicine:
Aciclovir eye ointment 3% (3 mg/g), 4.5 g
Brand name:
Xorox
Sponsor:
Clinect Pty Ltd
ARTG listing date:
6 November 2020
Country:
Australia
Indication:
Herpes simplex keratitis
Regulatory authority:
Therapeutic Goods Administration
Reimbursement scheme:
Pharmaceutical Benefits Scheme
PBAC status:
Not previously considered prior to this submission
Comparator products:
AciVision, Zovirax
Submission type:
Minor submission
Listing type requested:
Restricted benefit, General Schedule
Prescriber types:
Medical practitioners, nurse practitioners, optometrists
Legal framework:
Therapeutic Goods Act 1989, Section 19A
Period discussed:
2014–2021
Source type:
Public Summary Document
Year:
2019
Region / city:
Australia
Subject:
Medical Device Registration
Document Type:
Medical Application
Organization:
Seqirus (Australia) Pty Ltd
Author:
Seqirus
Target Audience:
Medical practitioners, optometrists, and healthcare professionals
Period of validity:
Not specified
Approval Date:
July 2019
Modification Date:
Not specified
Year:
2014
Change Date:
January 10, 2014
Jurisdiction:
United States
Subject Area:
Eye conditions and visual impairment
Document Type:
Administrative guidance manual section
Issuing Body:
Department of Veterans Affairs
Regulatory References:
38 CFR 3.303(c); 38 CFR 3.306; 38 CFR 3.383(a); 38 CFR 4.25; 38 CFR 4.75; 38 CFR 4.77; 38 CFR 4.79
Related System:
Veterans Benefits Management System-Rating (VBMS-R)
Intended Audience:
VA adjudicators and medical examiners
Scope:
Service connection and evaluation of visual acuity, visual field loss, and specific eye conditions
Period of Application:
Applicable as of January 10, 2014
Medicine:
Ciclosporin 1 mg/mL (0.1%) eye drops
Brand name:
Ikervis®
Sponsor:
Seqirus (Australia) Pty Ltd
Regulatory authority:
Therapeutic Goods Administration (TGA)
Registration date:
11 December 2020
Program:
Pharmaceutical Benefits Scheme (PBS)
Restriction type:
Authority Required (Streamlined)
Schedule category:
GENERAL – General Schedule (Code GE)
Indication:
Treatment of severe keratitis in adult patients with dry eye disease not improved despite tear substitutes
Population:
Patients aged 18 years or older with severe keratitis and dry eye disease
Comparators:
Best supportive care including preservative free artificial tears
Clinical criteria (initiation):
Corneal fluorescein staining grade 4 (modified Oxford scale or equivalent) and OSDI ≥ 23; failure of optimised preservative free tear substitutes
Clinical criteria (continuation):
Demonstrated adequate response at 6 months
Definition of adequate response:
Improvement in CFS ≥ 3 grades and ≥ 30% improvement in OSDI from baseline
Prescriber restrictions:
Ophthalmologist or optometrist
Economic basis:
Cost-utility analysis versus best supportive care
Proposed treatment phases:
Initiation; continuation; continuation after assessment of response
Year:
2024
Region / city:
Southern New Hampshire University
Subject:
ADHD, Attention Disorders, School Programs
Document Type:
Program Overview
Organization / Institution:
Southern New Hampshire University
Author:
Michaela Carroll
Target Audience:
School-age children with attention disorders, educators, parents, clinicians
Period of Action:
June 16, 2024
Approval Date:
June 16, 2024
Modification Date:
N/A
Note:
Context
Year:
2023
Region / City:
United States
Subject:
Health and Human Services Terminology
Document Type:
Acronym List
Agency / Institution:
Administration for Children & Families
Author:
N/A
Target Audience:
Public, Governmental and Health Sector Professionals
Date Approved:
N/A
Date of Changes:
N/A
Note:
Year
Year:
Not specified
Region / City:
Rochester, Minnesota
Subject:
Mayo Clinic Locations
Document Type:
Address List
Organization / Institution:
Mayo Clinic
Target Audience:
Not specified
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
Pelham, NH
Topic:
Lacrosse Skills Clinic
Document Type:
Participant Release Form
Organization:
Pelham Parks and Recreation
Author:
Pelham Parks and Recreation
Target Audience:
Parents and children aged 6 and up
Period of Activity:
January 18 - February 15, 2026
Approval Date:
N/A
Date of Changes:
N/A